Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • Robert Ingram Joins Cree Board
Jan 2009
LED maker Cree Inc. of Durham, N.C., announced that Robert Ingram, vice chairman of pharmaceuticals for GlaxoSmithKline of Research Triangle Park, N.C., was elected to its board of directors and several board committees, effective immediately. Ingram has served in his current position at the pharmaceutical company since January 2003. He previously was chief operating officer and president of pharmaceutical operations at the company after the December 2000 merger of Glaxo Wellcome plc and SmithKline Beecham plc. Before the merger, he served in senior executive positions at several pharmaceutical companies. "His wealth of experience in research-intensive businesses facing global marketing and manufacturing challenges gives him an ideal foundation to help us address the opportunities Cree anticipates. The insights he brings should prove beneficial to Cree as we work toward our goal of replacing traditional lighting solutions with energy-efficient, environmentally friendly LED lighting," said Chuck Swoboda, Cree chairman and CEO.

The technology of generating and harnessing light and other forms of radiant energy whose quantum unit is the photon. The science includes light emission, transmission, deflection, amplification and detection by optical components and instruments, lasers and other light sources, fiber optics, electro-optical instrumentation, related hardware and electronics, and sophisticated systems. The range of applications of photonics extends from energy generation to detection to communications and...
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.